© 2022 254 North Front Street, Suite 300, Wilmington, NC 28401 | 910.343.1640
News Classical 91.3 Wilmington 92.7 Wilmington 96.7 Southport
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations

Neurontin

Michele Norris talks with NPR's Snigdha Prakash about actions by drug company Parke-Davis to promote the drug Neurontin for uses not yet approved by the government. NPR has obtained documents indicating that Tony Wild, then-president of Parke-Davis, was aware of the plan to work around FDA approval to promote the drug.

Copyright 2002 NPR